AstraZeneca announces new deals with biotechs

02/1/2007 | Bloomberg · Reuters

AstraZeneca said it will acquire U.K. biotech company Arrow Therapeutics for $150 million to boost research on bacteria and virus compounds, a day after announcing two licensing agreements worth $800 million to develop obesity and respiratory drugs. The drugmaker also announced plans to cut 3,000 jobs.

View Full Article in:

Bloomberg · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC